Absorption |
Blood-Brain Barrier | BBB+ | 0.7743 |
Human Intestinal Absorption | HIA+ | 0.9950 |
Caco-2 Permeability | Caco2+ | 0.7866 |
P-glycoprotein Substrate | Non-substrate | 0.6984 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9468 |
Non-inhibitor | 0.9555 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8937 |
Distribution |
Subcellular localization | Mitochondria | 0.8705 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7918 |
CYP450 2D6 Substrate | Non-substrate | 0.8828 |
CYP450 3A4 Substrate | Non-substrate | 0.6225 |
CYP450 1A2 Inhibitor | Inhibitor | 0.8026 |
CYP450 2C9 Inhibitor | Inhibitor | 0.8196 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8743 |
CYP450 2C19 Inhibitor | Inhibitor | 0.6554 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9158 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.7321 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9439 |
Non-inhibitor | 0.7426 |
AMES Toxicity | Non AMES toxic | 0.9415 |
Carcinogens | Non-carcinogens | 0.7793 |
Fish Toxicity | High FHMT | 0.9907 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9993 |
Honey Bee Toxicity | High HBT | 0.6242 |
Biodegradation | Not ready biodegradable | 0.9784 |
Acute Oral Toxicity | II | 0.7404 |
Carcinogenicity (Three-class) | Non-required | 0.5151 |